Immunocellular Therapeutics’ work in industry-leading, next-generation

- imuc.com

ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer immunotherapies for the treatment brain, ovarian and other solid tumors.

8,740,534 $ 240.00